Handelsbanken Fonder’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.9M | Buy |
79,811
+5,772
| +8% | +$2.14M | 0.09% | 197 |
|
|
2026
Q1 | $21.7M | Buy |
74,039
+1,402
| +2% | +$461K | 0.07% | 222 |
|
|
2025
Q4 | $25.5M | Sell |
72,637
-1,799
| -2% | -$608K | 0.08% | 223 |
|
|
2025
Q3 | $24.1M | Buy |
74,436
+1,297
| +2% | +$403K | 0.08% | 229 |
|
|
2025
Q2 | $28.4M | Buy |
73,139
+10,253
| +16% | +$4.12M | 0.1% | 189 |
|
|
2025
Q1 | $27.4M | Sell |
62,886
-570
| -0.9% | -$229K | 0.11% | 177 |
|
|
2024
Q4 | $23.4M | Sell |
63,456
-11,864
| -16% | -$4.96M | 0.09% | 205 |
|
|
2024
Q3 | $39.2M | Buy |
75,320
+2,987
| +4% | +$1.6M | 0.15% | 132 |
|
|
2024
Q2 | $39.2M | Sell |
72,333
-10,270
| -12% | -$5.43M | 0.17% | 117 |
|
|
2024
Q1 | $42.8M | Buy |
82,603
+4,831
| +6% | +$2.4M | 0.18% | 119 |
|
|
2023
Q4 | $36.7M | Buy |
77,772
+161
| +0.2% | +$74.4K | 0.18% | 127 |
|
|
2023
Q3 | $33.8M | Sell |
77,611
-292
| -0.4% | -$132K | 0.19% | 122 |
|
|
2023
Q2 | $34.6M | Buy |
77,903
+1,133
| +1% | +$523K | 0.19% | 124 |
|
|
2023
Q1 | $35.3M | Buy |
76,770
+4,073
| +6% | +$1.94M | 0.2% | 113 |
|
|
2022
Q4 | $37.3M | Buy |
72,697
+4,965
| +7% | +$2.52M | 0.23% | 106 |
|
|
2022
Q3 | $30.8M | Buy |
67,732
+2,903
| +4% | +$1.39M | 0.21% | 119 |
|
|
2022
Q2 | $31.3M | Buy |
64,829
+2,393
| +4% | +$1.18M | 0.2% | 118 |
|
|
2022
Q1 | $30.7M | Buy |
62,436
+1,550
| +3% | +$709K | 0.17% | 135 |
|
|
2021
Q4 | $28.2M | Buy |
60,886
+461
| +0.8% | +$194K | 0.14% | 166 |
|
|
2021
Q3 | $22.5M | Buy |
60,425
+1,274
| +2% | +$484K | 0.12% | 188 |
|
|
2021
Q2 | $22.6M | Sell |
59,151
-2,362
| -4% | -$903K | 0.12% | 185 |
|
|
2021
Q1 | $22.1M | Buy |
61,513
+2,460
| +4% | +$791K | 0.13% | 167 |
|
|
2020
Q4 | $19M | Buy |
59,053
+1,100
| +2% | +$338K | 0.12% | 186 |
|
|
2020
Q3 | $15.6M | Buy |
57,953
+200
| +0.3% | +$53.8K | 0.11% | 187 |
|
|
2020
Q2 | $15.2M | Buy |
+57,753
| New | +$15.4M | 0.13% | 155 |
|
|
2018
Q1 | – | Sell |
-5,000
| Closed | -$1.13M | – | 204 |
|
|
2017
Q4 | $1.13M | Buy |
+5,000
| New | +$1.06M | 0.02% | 164 |
|
|
2017
Q2 | – | Sell |
-48,000
| Closed | -$7.94M | – | 172 |
|
|
2017
Q1 | $7.94M | Buy |
48,000
+43,500
| +967% | +$6.92M | 0.22% | 94 |
|
|
2016
Q4 | $647K | Hold |
4,500
| – | – | 0.02% | 153 |
|
|
2016
Q3 | $564K | Sell |
4,500
-1,893
| -30% | -$244K | 0.02% | 157 |
|
|
2016
Q2 | $840K | Sell |
6,393
-74,000
| -92% | -$10.1M | 0.03% | 129 |
|
|
2016
Q1 | $11.2M | Sell |
80,393
-39,600
| -33% | -$5.29M | 0.48% | 71 |
|
|
2015
Q4 | $16.7M | Buy |
+119,993
| New | +$16.5M | 0.32% | 97 |
|
Other funds holding ELV
Handelsbanken Fonder's ELV Position: Q2 2026 in Review
Handelsbanken Fonder increased its Elevance Health (ELV) stake by 7.8% in Q2 2026, buying an estimated $2.14M and bringing the position to 79,811 shares worth $30.9M. The position accounts for 0.09% of the portfolio, ranked #197.
Handelsbanken Fonder first reported a position in ELV in Q4 2015 and has held it in 32 quarters since. The position peaked at $42.8M in Q1 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Handelsbanken Fonder held 79,811 shares of Elevance Health worth $30.9M as of Q2 2026.
- Handelsbanken Fonder bought 5,772 Elevance Health shares in Q2 2026, an estimated $2.14M.
- Elevance Health made up 0.09% of Handelsbanken Fonder's portfolio in Q2 2026, its #197 holding.
- Handelsbanken Fonder first reported a position in Elevance Health in Q4 2015 and has held it in 32 quarters since.
- Handelsbanken Fonder's Elevance Health position peaked at $42.8M in Q1 2024.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.